Why Novanta Inc.’s (NOVT) Stock Is Down 5.35%
As of Thursday, October 08, Novanta Inc.’s NOVT share price has dipped by 5.35%, which has investors questioning if this is right time to buy.Jenna Brashear
Stock Evaluator: Novanta Inc. (NOVT)
Novanta Inc. NOVT
$149.87
3.63
2.48%
November 3, 2026 10:30:29 AM
EST
Volume: 25,661
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Information Technology | Electronic Equipment, Instruments & Components |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.
Commentary & Analysis
Why Novanta Inc.’s (NOVT) Stock Is Up 5.27%
As of Friday, October 02, Novanta Inc.’s NOVT share price has surged by 5.27%, which has investors questioning if this is right time to sell.Michael Rose
Which Is a Better Investment, Netlist, Inc. or Novanta Inc. Stock?
Learn more about whether Netlist, Inc. or Novanta Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Jenna Brashear
Why Novanta Inc.’s (NOVT) Stock Is Down 5.08%
As of Monday, September 14, Novanta Inc.’s NOVT share price has dipped by 5.08%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Novanta Inc.’s (NOVT) Stock Is Down 5.08%
As of Tuesday, August 18, Novanta Inc.’s NOVT share price has dipped by 5.08%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | NOVT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,530.8 | $1,143.2 | 69% |
|
| Shares Out (Mil) | 41.2 | 28.9 | 43% |
|
| Institutional Ownership | 49.7% | 81.6% | 25% |
|
| Float (Mil) | 37.5 | 39.7 | 40% |
|
| Beta | 1.68 | 1.13 | 86% |
|
| Avg Daily Volume (000s) | 381 | 202 | 55% |
|
| Price Change (52-week) |
16.8% | 60.2% | 65% |
|
| Growth | NOVT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.7% | 4.9% | 61% |
|
| Net Income (5yr) | 3.9% | 2.6% | 45% |
|
| EPS (5yr) | 3.3% | 8.6% | 36 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 41.0% | (14.9%) | 91% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | $0.967 | $3.693 | $4.367 | |
| Month Ago EPS | $0.967 | $3.693 | $4.367 | |
| # Rev Up | 2 | 0 | 0 | |
| # Rev Down | 1 | 2 | 1 | |
| Three Months Ago EPS | $0.940 | $3.590 | $4.143 | |
| Year/Year Chg | 222.3% | 151.2% | na | |
| Financials | NOVT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,030 | $572 | 50% |
|
| Net Income (TTM) (Mil) | $62 | $12 | 56% |
|
| EPS (TTM) | $1.586 | $0.300 | 67% |
|
| Operating Cash Flow (TTM) (Mil) | $134 | $12 | 55% |
|
| Net Cash Flow (TTM) (Mil) | $609 | $7 | 92% |
|
| Long-Term Debt (Q1) (Mil) | $233 | $22 | 51% |
|
| Enterprise Value (Q1) (Mil) | $4,618 | $1,158 | 62% |
|
| Valuation | NOVT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.42 | 2.21 | 72% |
|
| P/E | 92.4 | 30.2 | 93% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 28.0 | 1.6 | 98% |
|
| Ratios | NOVT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 44.5% | 32.7% | 55% |
|
| Net Margin | 6.0% | 2.7% | 51% |
|
| ROA | 3.4% | 2.4% | 63% |
|
| ROE | 5.1% | 5.1% | 44% |
|
| Liabilities to Assets | 24.4% | 41.7% | 16% |
|
| F-Score | 5 | 5 | 50% |
|
Novanta Inc. did not pass any screens on 11/2/2026.
